Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-27 @ 2:58 AM
Study NCT ID:
NCT02433093
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2015-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-29
First Submit QC Date:
None
Study First Post Date:
2015-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-01
Last Update Post Date:
2016-11-02
Last Update Post Date Type:
ESTIMATED